BioRender 图标

TA-MUC1

TA-MUC1 - Editable icon of a TA-MUC1 membrane bound protein in a schematic representation
[{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a953749cad1a/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a953749cad1a/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a904bc9cad19/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a904bc9cad19/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a95d0a9cad18/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a95d0a9cad18/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91c8a9cad17/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91c8a9cad17/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a962c19cad16/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a962c19cad16/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92f419cad15/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92f419cad15/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9a3b79cad14/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9a3b79cad14/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9ff769cad13/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9ff769cad13/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92b439cad12/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92b439cad12/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91ca89cad11/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91ca89cad11/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a951a09cad10/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a951a09cad10/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b5229cad0f/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b5229cad0f/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9146b9cad0e/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9146b9cad0e/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a93c5c9cad0d/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a93c5c9cad0d/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b0509cad0c/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b0509cad0c/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9284e9cad0b/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9284e9cad0b/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a96d219cad0a/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a96d219cad0a/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a94a0e9cad09/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a94a0e9cad09/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a97f4e9cad08/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a97f4e9cad08/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a952b39cad07/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a952b39cad07/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9f09d9cad06/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9f09d9cad06/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a925e59cad05/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a925e59cad05/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a963379cad04/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a963379cad04/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a954e39cad03/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a954e39cad03/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a94cfb9cad02/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a94cfb9cad02/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a994d09cad01/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a994d09cad01/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a946749cad00/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a946749cad00/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a934c99cacff/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a934c99cacff/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a907989cacfe/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a907989cacfe/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9accd9cacfd/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9accd9cacfd/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a998de9cacfc/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a998de9cacfc/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9001b9cacfb/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9001b9cacfb/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9cac39cacfa/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9cac39cacfa/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92fd59cacf9/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92fd59cacf9/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a91eb39cacf8/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a91eb39cacf8/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a980f09cacf7/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a980f09cacf7/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a96ec69cacf6/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a96ec69cacf6/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9f96f9cacf5/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9f96f9cacf5/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9bdc89cacf4/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9bdc89cacf4/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9ffbc9cacf3/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9ffbc9cacf3/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a919ad9cacf2/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a919ad9cacf2/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a922539cacf1/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a922539cacf1/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9b0ea9cacf0/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9b0ea9cacf0/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a939189cacef/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a939189cacef/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a981c59cacee/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a981c59cacee/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a92df09caced/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a92df09caced/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a908609cacec/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a908609cacec/65c0fcbfdd873ad09e4e1d03.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/65c0feb67ea8a9300e9caceb/65c0fcbfdd873ad09e4e1d03.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/65c0feb67ea8a9300e9caceb/65c0fcbfdd873ad09e4e1d03.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
TA-MUC1,mucin,muc,muc1,tumor,tumour,associated,tumor associated,membrane bound,bound,membrane,SEA domain,glycosylated sugar chain,glycosylated,glycoconjugates,sugar,glycan,Tn,sTn,sTF,chain,glycans,cytoplasmic tail,gel,secretion,lubrication,cell signaling,chemical barrier,inhibitory,mineralization,epithelial,TA-MUC1
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

TA-MUC1 icon JPEG

TA-MUC1 icon PNG

TA-MUC1 icon SVG

TA-MUC1 icon GIF

BioRender 图标常见问题解答

How are scientists using the TA-MUC1 icon in their work?

BioRender users often use the TA-MUC1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Proteins.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the TA-MUC1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the TA-MUC1 icon customizable in BioRender?

Most icons in BioRender, including the TA-MUC1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the TA-MUC1 icon for publication or presentations?

Yes, figures containing the TA-MUC1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the TA-MUC1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the TA-MUC1 icon — especially those focused on Proteins. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this TA-MUC1 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon